These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
172 related articles for article (PubMed ID: 24079546)
1. Cyclodextrin derivatives conjugated with aromatic moieties as pH-responsive drug carriers for anthracycline. Swiech O; Dutkiewicz P; Wójciuk K; Chmurski K; Kruszewski M; Bilewicz R J Phys Chem B; 2013 Oct; 117(43):13444-50. PubMed ID: 24079546 [TBL] [Abstract][Full Text] [Related]
2. Design and evaluation of folate-appended α-, β-, and γ-cyclodextrins having a caproic acid as a tumor selective antitumor drug carrier in vitro and in vivo. Okamatsu A; Motoyama K; Onodera R; Higashi T; Koshigoe T; Shimada Y; Hattori K; Takeuchi T; Arima H Biomacromolecules; 2013 Dec; 14(12):4420-8. PubMed ID: 24175976 [TBL] [Abstract][Full Text] [Related]
3. Norbornene derived doxorubicin copolymers as drug carriers with pH responsive hydrazone linker. Rao N V; Mane SR; Kishore A; Das Sarma J; Shunmugam R Biomacromolecules; 2012 Jan; 13(1):221-30. PubMed ID: 22107051 [TBL] [Abstract][Full Text] [Related]
4. P-Sulfocalix[6]arene as Nanocarrier for Controlled Delivery of Doxorubicin. Ostos FJ; Lebrón JA; Moyá ML; López-López M; Sánchez A; Clavero A; García-Calderón CB; Rosado IV; López-Cornejo P Chem Asian J; 2017 Mar; 12(6):679-689. PubMed ID: 28112869 [TBL] [Abstract][Full Text] [Related]
5. Poly(amidoamine) conjugates containing doxorubicin bound via an acid-sensitive linker. Lavignac N; Nicholls JL; Ferruti P; Duncan R Macromol Biosci; 2009 May; 9(5):480-7. PubMed ID: 19016501 [TBL] [Abstract][Full Text] [Related]
6. Folate-decorated maleilated pullulan-doxorubicin conjugate for active tumor-targeted drug delivery. Zhang H; Li F; Yi J; Gu C; Fan L; Qiao Y; Tao Y; Cheng C; Wu H Eur J Pharm Sci; 2011 Apr; 42(5):517-26. PubMed ID: 21352909 [TBL] [Abstract][Full Text] [Related]
7. Comparative studies of polyethylenimine-doxorubicin conjugates with pH-sensitive and pH-insensitive linkers. Dong DW; Tong SW; Qi XR J Biomed Mater Res A; 2013 May; 101(5):1336-44. PubMed ID: 23065848 [TBL] [Abstract][Full Text] [Related]
8. Effect of structural modifications of anthracyclines on the ability to overcome drug resistance of cancer cells. Wasowska M; Wietrzyk J; Opolski A; Oszczapowicz J; Oszczapowicz I Anticancer Res; 2006; 26(3A):2009-12. PubMed ID: 16827137 [TBL] [Abstract][Full Text] [Related]
9. Poly (ethylene glycol) prodrug for anthracyclines via N-Mannich base linker: design, synthesis and biological evaluation. Zhao YJ; Wei W; Su ZG; Ma GH Int J Pharm; 2009 Sep; 379(1):90-9. PubMed ID: 19540322 [TBL] [Abstract][Full Text] [Related]
10. Star-shaped immunoglobulin-containing HPMA-based conjugates with doxorubicin for cancer therapy. Etrych T; Mrkvan T; Ríhová B; Ulbrich K J Control Release; 2007 Sep; 122(1):31-8. PubMed ID: 17631976 [TBL] [Abstract][Full Text] [Related]
11. Active Drug Targeting of a Folate-Based Cyclodextrin-Doxorubicin Conjugate and the Cytotoxic Effect on Drug-Resistant Mammary Tumor Cells In Vitro. Mizusako H; Tagami T; Hattori K; Ozeki T J Pharm Sci; 2015 Sep; 104(9):2934-40. PubMed ID: 25940848 [TBL] [Abstract][Full Text] [Related]
12. Oxidized phospholipid based pH sensitive micelles for delivery of anthracyclines to resistant leukemia cells in vitro. Wang Y; Chen L; Ding Y; Yan W Int J Pharm; 2012 Jan; 422(1-2):409-17. PubMed ID: 22037443 [TBL] [Abstract][Full Text] [Related]
13. Enhanced anti-cancer efficacy to cancer cells by doxorubicin loaded water-soluble amino acid-modified β-cyclodextrin platinum complexes. Zhao MX; Zhao M; Zeng EZ; Li Y; Li JM; Cao Q; Tan CP; Ji LN; Mao ZW J Inorg Biochem; 2014 Aug; 137():31-9. PubMed ID: 24803024 [TBL] [Abstract][Full Text] [Related]
14. Dual stimuli-responsive polymeric hollow nanogels designed as carriers for intracellular triggered drug release. Chiang WH; Ho VT; Huang WC; Huang YF; Chern CS; Chiu HC Langmuir; 2012 Oct; 28(42):15056-64. PubMed ID: 23036055 [TBL] [Abstract][Full Text] [Related]
15. Biodegradable ZnO@polymer core-shell nanocarriers: pH-triggered release of doxorubicin in vitro. Zhang ZY; Xu YD; Ma YY; Qiu LL; Wang Y; Kong JL; Xiong HM Angew Chem Int Ed Engl; 2013 Apr; 52(15):4127-31. PubMed ID: 23463695 [No Abstract] [Full Text] [Related]
16. Doxorubicin delivery by polyamidoamine dendrimer conjugation and photochemical internalization for cancer therapy. Lai PS; Lou PJ; Peng CL; Pai CL; Yen WN; Huang MY; Young TH; Shieh MJ J Control Release; 2007 Sep; 122(1):39-46. PubMed ID: 17628166 [TBL] [Abstract][Full Text] [Related]
17. Novel folated and non-folated pullulan bioconjugates for anticancer drug delivery. Scomparin A; Salmaso S; Bersani S; Satchi-Fainaro R; Caliceti P Eur J Pharm Sci; 2011 Apr; 42(5):547-58. PubMed ID: 21371555 [TBL] [Abstract][Full Text] [Related]
18. Influence of the structure of new anthracycline antibiotics on their biological properties. Wasowska M; Oszczapowicz I; Wietrzyk J; Opolski A; Madej J; Dzimira S; Oszczapowicz J Anticancer Res; 2005; 25(3B):2043-8. PubMed ID: 16158943 [TBL] [Abstract][Full Text] [Related]
19. Reversing the undesirable pH-profile of doxorubicin via activation of a di-substituted maleamic acid prodrug at tumor acidity. Zhang A; Yao L; An M Chem Commun (Camb); 2017 Nov; 53(95):12826-12829. PubMed ID: 29143021 [TBL] [Abstract][Full Text] [Related]
20. Effects of structural modification of the daunosamine moiety of anthracycline antibiotics on pK Matyjaszczyk K; Kolonko M; Gonciarz-Dytman A; Oszczapowicz I; Łukawska M; Jawień W; Chlopicki S; Walczak M J Chromatogr B Analyt Technol Biomed Life Sci; 2017 Aug; 1060():44-52. PubMed ID: 28599260 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]